New Key Statistics Module, Z-Score and F-Score
NAS:ITCI Key Ratios
| Market Cap $ M | 9,117.47 |
| Enterprise Value $ M | 8,048.05 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | 229.33 |
| Price/Book | 7.96 |
| Price/Sales | 14.16 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 612.00 |
| EPS (TTM) $ | -0.87 |
| Beneish M-Score | 90.8 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | 7.70 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -66.84 |
| EV-to-EBITDA | -67.13 |
| PEG | -- |
| Shares Outstanding M | 106.02 |
| Net Margin (%) | -14.10 |
| Operating Margin % | -19.85 |
| Pre-tax Margin (%) | -13.89 |
| Quick Ratio | 7.51 |
| Current Ratio | 7.66 |
| ROA % (ttm) | -8.93 |
| ROE % (ttm) | -10.58 |
| ROIC % (ttm) | -77.81 |
| Dividend Yield % | -- |
| Altman Z-Score | 29.94 |
ITCI Number of Guru Trades
ITCI Volume of Guru Trades
Gurus Latest Trades with NAS:ITCI
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:ITCI is held by these investors
Total 1
Intra-Cellular Therapies Inc Insider Transactions
No Available Data
News about NAS:ITCI
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers